Triamcinolone Acetonide
FDA recalls
5 rows
| Date | Company and reason |
|---|---|
| Sep 27, 2023 | Eugia US LLC Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial. |
| Aug 16, 2022 | Padagis US LLC CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness. |
| Apr 12, 2022 | McKesson Medical-Surgical Inc. Corporate Office cGMP deviations: Temperature abuse |
| Mar 14, 2021 | Cardinal Health Inc. CGMP Deviations: Intermittent exposure to temperature excursion during storage. |
| Jan 28, 2014 | Fougera Pharmaceuticals Inc. Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%. |
← Back to Triamcinolone Acetonide
Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).